1 / 13

Using air quality monitoring data for public health action: Health Impact Assessment Studies

Using air quality monitoring data for public health action: Health Impact Assessment Studies. Marco Martuzzi World Health Organisation, Regional Office for Europe European Centre for Environment and Health, Rome Division. Rationale.

micah
Télécharger la présentation

Using air quality monitoring data for public health action: Health Impact Assessment Studies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Using air quality monitoring data for public health action:Health Impact Assessment Studies Marco Martuzzi World Health Organisation, Regional Office for Europe European Centre for Environment and Health, Rome Division

  2. Rationale • Clinical and epidemiological evidence on health effects of outdoor air pollution is abundant • Risks have been identified, and dose-response relationships have been characterised for several pollutants and health endpoints • Compared to other risk factors risks are small • Exposure is ubiquitous, majority of people exposed • Need to assess overall public health relevance of air pollution • Air quality monitoring data increasingly available

  3. Assessing the impact • Policy makers under growing pressure • Underlying cost-benefit type question, “what would we gain if we could reduce concentrations to X?” • Recent research has addressed this issue • Metrics for health impact: attributable risks (risk assessment studies), years of life lost (YLL), and economic evaluations • Air pollution impact studies have been published, e.g., France-Switzerland-Austria (Kuenzli 2000); UK (Hurley 2000), Italy (submitted), US, …

  4. Methods for air pollution HIA • Use PM as a summary indicator of all pollutants (cannot evaluate separate roles); recent studies include ozone • Risk functions for selected outcomes • Exposure estimates, usually average concentrations for large population • Observed rates or prevalence • “Prudent” estimates, i.e., identify part of the health effects effectively attributable to AP

  5. 8 Italian Cities • PM10 data from monitoring stations • Mortality, morbidity, hospital admission • Average concentration 52.6 g/m3 • Estimate rates or prevalences predicted at lower concentrations • Compare with observed rates • Reference PM10 levels: 20, 30, 40 g/m3 • “Conservative” risk coefficients, e.g. for long term mortality: 1.026 / 10 g/m3 (95% CI 1.009 – 1.043)

  6. Methods E=A*B*C*P A = Attributable proportion [(RR-1)/RR] B = occurrence of health endpoint C = change in concentration (from reference value) P = exposed population

  7. Mortality • Long term effects (from cohort studies), age 30+, excluding accidental causes: Austria 5,600; France 31,700; Switzerland 3,300 • PM10 reference level: 7.5 g/m3 • Dose response coefficient for mortality: 1.04 / g/m3 • But who dies? When? (Important especially for economic evaluation) • UK study: estimate YLL

  8. Health Impact studies • “First generation” studies • Rough approximations involved, generally thought to be “conservative” • Work is needed, two levels: • Methods for risk assessment of air pollution • Interpretation and use of results in public health and risk management

  9. Methods for AP risk assessment • Validity of average concentrations (consistent with epidemiological studies) • Extrapolation across populations • Naïve estimates of uncertainty • Different pollutants (ozone probably needs separate treatment) • Better dose-response models • More health endpoints, esp. short- vs. long-term effects

  10. Interpretation • Attributable vs preventable • Susceptible subgroups (the elderly being a group of special interest) • Consider realistic scenarios of reduction of concentrations • Risk assessment vs HIA assessment (e.g., of transport policies)

  11. Conclusions • HIA studies useful to fill the knowledge gap between laboratory, clinical, epidemiological evidence and public health policy • Make public health action on AP more compelling • Need to improve methodology and evaluate implications more thoroughly (possibly better communication) • Quality and completeness of AP data has been improving • Still need: higher spatial resolution, partitioning of sources • HIA transport: Noise, accidents, cycling and walking, psychosocial effects

More Related